Discover How the World #1 Oral Exam Can Benefit Your Practice
Visualize
Experience how the FDA approved WHO recommended Velscan Tissue Fluorescence Visualization help assist you detect lesions like never before. Patient documentation with advanced imaging helps communicate and educate patients about treatment protocols.
Identify
Bacterial, viral, fungal infections, squamous papilloma, salivary gland tumors, lichen planus, leukoplakia including cancerous, pre-cancerous and other lesions which may not be visible to the naked eye can be identified with ease using Velscan.
Diagnose
Squamous epithelial cells collected on soft Orcellex® brush are analyzed for abnormal aneuploid cells which can grow to become cancerous 3-5 years before visible symptoms using BC Cancer Research developed quantitative DNA Ploidy test and conventional PAP Test.
Treat
Abnormal cells (pre cancer or cancerous) detected can then be easily treated as per treatment protocol suitable to the patient’s individual condition. Other disease can be treated using suitable treatment option and photographic documentation can provide patients the peace of mind they seek.
Surgical Margins
The VELscope Vx System is used to help surgeons determine the appropriate surgical margin when excision is indicated. The fact is that fluorescence allows you to see mucosal changes that may be very hard to see based on conventional visualization. Research suggests that VELscope guided surgery can reduce local recurrence rate from 40.6% to 6.5%
Tissue Fluorescence
The VELscope Vx emits a safe, blue light into the oral cavity, which excites the oral tissue and causes it to fluoresce. It helps doctors to see abnormalities that may be invisible to a naked eye in white light. The oral cavity can then be examined in real time and suspicious tissue that may require further investigation can be quickly identified.
VelScan Documentation
Advanced imaging lets you document clinical findings, share with patients in real-time and provide evidence-based care. Routine photo documentation helps communicate and educate patients about treatment protocols, demonstrate pre-treatment and post-treatment results and build the trust with your patients.
Save Lives
World’s most advanced and accurate quantitative DNA Ploidy test can empower you to detect aneuploidy in suspicious oral cells, up to 2 years earlier than cytology or histology alone. This will enable you to diagnose possible oral cancers at very early stage, enabling effective early stage treatment options with highest success rates.
VELscan OPD Live
A unique opportunity to try VELscan program at your own clinic. Discover how only 2 minutes routine VELscan exam performed on every visitor will change your practice. Make sure your patients love it!
Used by World’s Best
The early disease discovery system used by the TOP oral healthcare practitioners globally can now be available at your practice. More than 25 million VELscope® Vx examinations have been performed by over 15,000 dental practitioners in 23 countries.
WHO Recommended
VELscope® Vx is recognized by World Health Organization (WHO). It is the first technology approved by the USA FDA and Health Canada for early detection of cancerous and precancerous lesions, that might be invisible to the naked eye, and to help determine the appropriate surgical margin when excision is indicated.
Google: Velscope
The award-winning VELscope® Vx is the world’s most widely used device for the enhanced visualization of oral mucosal abnormalities. The technology is backed by more clinical studies than any other device for TFV. Just do your own research – Google VELscope.
CONTACT US
+91 999 044 4646
info@velscan.com
203 Varun Capital, Jangali Maharaj Rd, Pune, Maharashtra 411005
